# Block, Inc.: financial statements, quarterly

XYZ · NYSE · CIK 1512673 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xyz.md) · [Financials](/companies/xyz/financials.md) · [Filings](/companies/xyz/filings.md) · [Insiders](/companies/xyz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xyz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,617](/filings/0001628280-24-046294.md) | [5,773 d](/filings/0001628280-26-012254.md) | [5,957](/filings/0001628280-25-021538.md) | [6,156](/filings/0001628280-25-038920.md) | [5,976](/filings/0001628280-25-050234.md) | [6,033 d](/filings/0001628280-26-012254.md) | [5,772](/filings/0001628280-26-032200.md) | [6,054](/filings/0001628280-26-053368.md) | [6,115](/filings/0001628280-25-050234.md) | [6,252 d](/filings/0001628280-26-012254.md) | [6,057](/filings/0001628280-26-032200.md) | [6,618](/filings/0001628280-26-053368.md) |
| Cost of revenue | $m | [3,719](/filings/0001628280-24-046294.md) | [3,747 d](/filings/0001628280-26-012254.md) | [3,863](/filings/0001628280-25-021538.md) | [3,922](/filings/0001628280-25-038920.md) | [3,726](/filings/0001628280-25-050234.md) | [3,721 d](/filings/0001628280-26-012254.md) | [3,482](/filings/0001628280-26-032200.md) | [3,518](/filings/0001628280-26-053368.md) | [3,453](/filings/0001628280-25-050234.md) | [3,380 d](/filings/0001628280-26-012254.md) | [3,148](/filings/0001628280-26-032200.md) | [3,452](/filings/0001628280-26-053368.md) |
| Gross profit | $m | [1,898](/filings/0001628280-24-046294.md) | [2,026 d](/filings/0001628280-26-012254.md) | [2,094](/filings/0001628280-25-021538.md) | [2,233](/filings/0001628280-25-038920.md) | [2,250](/filings/0001628280-25-050234.md) | [2,311 d](/filings/0001628280-26-012254.md) | [2,290](/filings/0001628280-26-032200.md) | [2,537](/filings/0001628280-26-053368.md) | [2,662](/filings/0001628280-25-050234.md) | [2,872 d](/filings/0001628280-26-012254.md) | [2,909](/filings/0001628280-26-032200.md) | [3,166](/filings/0001628280-26-053368.md) |
| Research and development | $m | [714](/filings/0001628280-24-046294.md) | [685 d](/filings/0001628280-26-012254.md) | [721](/filings/0001628280-25-021538.md) | [713](/filings/0001628280-25-038920.md) | [711](/filings/0001628280-25-050234.md) | [770 d](/filings/0001628280-26-012254.md) | [761](/filings/0001628280-26-032200.md) | [725](/filings/0001628280-26-053368.md) | [711](/filings/0001628280-25-050234.md) | [711 d](/filings/0001628280-26-012254.md) | [1,039](/filings/0001628280-26-032200.md) | [609](/filings/0001628280-26-053368.md) |
| Operating income | $m | [(9.9)](/filings/0001628280-24-046294.md) | [(131) d](/filings/0001628280-26-012254.md) | [250](/filings/0001628280-25-021538.md) | [307](/filings/0001628280-25-038920.md) | [323](/filings/0001628280-25-050234.md) | [13.0 d](/filings/0001628280-26-012254.md) | [329](/filings/0001628280-26-032200.md) | [484](/filings/0001628280-26-053368.md) | [409](/filings/0001628280-25-050234.md) | [485 d](/filings/0001628280-26-012254.md) | [(172)](/filings/0001628280-26-032200.md) | [447](/filings/0001628280-26-053368.md) |
| Income tax | $m | [81.1](/filings/0001628280-24-046294.md) | [(59.9) d](/filings/0001628280-26-012254.md) | [35.5](/filings/0001628280-25-021538.md) | [59.0](/filings/0001628280-25-038920.md) | [43.0](/filings/0001628280-25-050234.md) | [(1,300)](/filings/0001628280-25-007376.md) | [38.3](/filings/0001628280-26-032200.md) | [121](/filings/0001628280-26-053368.md) | [140](/filings/0001628280-25-050234.md) | [86.4 d](/filings/0001628280-26-012254.md) | [(84.0)](/filings/0001628280-26-032200.md) | [214](/filings/0001628280-26-053368.md) |
| Net income | $m | [(88.7)](/filings/0001628280-24-046294.md) | [102 d](/filings/0001628280-26-012254.md) | [472](/filings/0001628280-25-021538.md) | [195](/filings/0001628280-25-038920.md) | [284](/filings/0001628280-25-050234.md) | [1,946 d](/filings/0001628280-26-012254.md) | [190](/filings/0001628280-26-032200.md) | [538](/filings/0001628280-26-053368.md) | [462](/filings/0001628280-25-050234.md) | [116 d](/filings/0001628280-26-012254.md) | [(309)](/filings/0001628280-26-032200.md) | [88.5](/filings/0001628280-26-053368.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001628280-24-046294.md) | not reported | [0.74](/filings/0001628280-25-021538.md) | [0.31](/filings/0001628280-25-038920.md) | [0.45](/filings/0001628280-25-050234.md) | not reported | [0.30](/filings/0001628280-26-032200.md) | [0.87](/filings/0001628280-26-053368.md) | [0.74](/filings/0001628280-25-050234.md) | not reported | [(0.52)](/filings/0001628280-26-032200.md) | [0.15](/filings/0001628280-26-053368.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001628280-24-046294.md) | not reported | [0.77](/filings/0001628280-25-021538.md) | [0.32](/filings/0001628280-25-038920.md) | [0.46](/filings/0001628280-25-050234.md) | not reported | [0.31](/filings/0001628280-26-032200.md) | [0.88](/filings/0001628280-26-053368.md) | [0.76](/filings/0001628280-25-050234.md) | not reported | [(0.52)](/filings/0001628280-26-032200.md) | [0.15](/filings/0001628280-26-053368.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [5.1](/filings/0001628280-24-046294.md) | [5.0](/filings/0001628280-26-012254.md) | [5.8](/filings/0001628280-25-021538.md) | [7.8](/filings/0001628280-25-038920.md) | [8.3](/filings/0001628280-25-050234.md) | [8.1](/filings/0001628280-26-012254.md) | [7.1](/filings/0001628280-26-032200.md) | [6.4](/filings/0001628280-26-053368.md) | [8.3](/filings/0001628280-25-050234.md) | [6.6](/filings/0001628280-26-053368.md) | [6.9](/filings/0001628280-26-032200.md) | [6.4](/filings/0001628280-26-053368.md) |
| Current assets | $bn | [17.5](/filings/0001628280-23-036406.md) | [17.8](/filings/0001628280-25-007376.md) | [20.5](/filings/0001628280-24-020025.md) | [22.3](/filings/0001628280-24-034157.md) | [20.8](/filings/0001628280-24-046294.md) | [19.9](/filings/0001628280-26-012254.md) | [19.7](/filings/0001628280-25-021538.md) | [19.7](/filings/0001628280-25-038920.md) | [22.1](/filings/0001628280-25-050234.md) | [22.9](/filings/0001628280-26-053368.md) | [23.8](/filings/0001628280-26-032200.md) | [23.1](/filings/0001628280-26-053368.md) |
| Total assets | $bn | [32.6](/filings/0001628280-23-036406.md) | [33.0](/filings/0001628280-25-007376.md) | [35.6](/filings/0001628280-24-020025.md) | [37.5](/filings/0001628280-24-034157.md) | [36.4](/filings/0001628280-24-046294.md) | [36.8](/filings/0001628280-26-012254.md) | [36.4](/filings/0001628280-25-021538.md) | [36.9](/filings/0001628280-25-038920.md) | [39.2](/filings/0001628280-25-050234.md) | [39.5](/filings/0001628280-26-053368.md) | [40.0](/filings/0001628280-26-032200.md) | [39.2](/filings/0001628280-26-053368.md) |
| Current liabilities | $bn | [9.2](/filings/0001628280-23-036406.md) | [8.9](/filings/0001628280-25-007376.md) | [12.5](/filings/0001628280-24-020025.md) | [12.2](/filings/0001628280-24-034157.md) | [10.0](/filings/0001628280-24-046294.md) | [8.5](/filings/0001628280-26-012254.md) | [8.7](/filings/0001628280-25-021538.md) | [10.1](/filings/0001628280-25-038920.md) | [10.1](/filings/0001628280-25-050234.md) | [10.4](/filings/0001628280-26-053368.md) | [12.0](/filings/0001628280-26-032200.md) | [10.5](/filings/0001628280-26-053368.md) |
| Total liabilities | $bn | [14.7](/filings/0001628280-23-036406.md) | [14.3](/filings/0001628280-25-007376.md) | [16.6](/filings/0001628280-24-020025.md) | [18.3](/filings/0001628280-24-034157.md) | [16.4](/filings/0001628280-24-046294.md) | [15.5](/filings/0001628280-26-012254.md) | [15.0](/filings/0001628280-25-021538.md) | [14.7](/filings/0001628280-25-038920.md) | [16.7](/filings/0001628280-25-050234.md) | [17.4](/filings/0001628280-26-053368.md) | [18.3](/filings/0001628280-26-032200.md) | [17.1](/filings/0001628280-26-053368.md) |
| Long-term debt | $bn | not reported | [4.1](/filings/0001628280-24-046294.md) | [4.1](/filings/0001628280-24-020025.md) | [6.1](/filings/0001628280-24-034157.md) | [6.1](/filings/0001628280-24-046294.md) | [6.1](/filings/0001628280-25-050234.md) | [5.1](/filings/0001628280-25-021538.md) | [5.1](/filings/0001628280-25-038920.md) | [7.3](/filings/0001628280-25-050234.md) | [7.3](/filings/0001628280-26-053368.md) | [7.3](/filings/0001628280-26-032200.md) | [5.7](/filings/0001628280-26-053368.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [17.8](/filings/0001628280-23-036406.md) | [18.7](/filings/0001628280-25-007376.md) | [19.0](/filings/0001628280-24-020025.md) | [19.3](/filings/0001628280-24-034157.md) | [19.9](/filings/0001628280-24-046294.md) | [21.3](/filings/0001628280-26-012254.md) | [21.5](/filings/0001628280-25-021538.md) | [22.2](/filings/0001628280-25-038920.md) | [22.5](/filings/0001628280-25-050234.md) | [22.2](/filings/0001628280-26-053368.md) | [21.7](/filings/0001628280-26-032200.md) | [22.0](/filings/0001628280-26-053368.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [491 d](/filings/0001628280-24-046294.md) | [(798) d](/filings/0001628280-26-012254.md) | [489](/filings/0001628280-25-021538.md) | [519 d](/filings/0001628280-25-038920.md) | [685 d](/filings/0001628280-25-050234.md) | [13.8 d](/filings/0001628280-26-012254.md) | [133](/filings/0001628280-26-032200.md) | [374 d](/filings/0001628280-26-053368.md) | [1,451 d](/filings/0001628280-25-050234.md) | [621 d](/filings/0001628280-26-012254.md) | [966](/filings/0001628280-26-032200.md) | [1,020 d](/filings/0001628280-26-053368.md) |
| Capital expenditure | $m | [37.7 d](/filings/0001628280-24-046294.md) | [51.7 d](/filings/0001628280-26-012254.md) | [32.0](/filings/0001628280-25-021538.md) | [38.4 d](/filings/0001628280-25-038920.md) | [56.6 d](/filings/0001628280-25-050234.md) | [27.0 d](/filings/0001628280-26-012254.md) | [31.9](/filings/0001628280-26-032200.md) | [31.3 d](/filings/0001628280-26-053368.md) | [50.6 d](/filings/0001628280-25-050234.md) | [41.2 d](/filings/0001628280-26-012254.md) | [30.6](/filings/0001628280-26-032200.md) | [53.2 d](/filings/0001628280-26-053368.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-046294.md) | [157 d](/filings/0001628280-26-012254.md) | [252](/filings/0001628280-25-021538.md) | [390 d](/filings/0001628280-25-038920.md) | [346 d](/filings/0001628280-25-050234.md) | [183 d](/filings/0001628280-26-012254.md) | [445](/filings/0001628280-26-032200.md) | [692 d](/filings/0001628280-26-053368.md) | [403 d](/filings/0001628280-25-050234.md) | [790 d](/filings/0001628280-26-012254.md) | [636](/filings/0001628280-26-032200.md) | [64.9 d](/filings/0001628280-26-053368.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [593](/filings/0001628280-23-036406.md) | [624](/filings/0001628280-24-020025.md) | [607](/filings/0001628280-24-034157.md) | [611](/filings/0001628280-24-046294.md) | [637](/filings/0001628280-25-021538.md) | [634](/filings/0001628280-25-038920.md) | [633](/filings/0001628280-25-050234.md) | [635](/filings/0001628280-26-032200.md) | [619](/filings/0001628280-26-053368.md) | [622](/filings/0001628280-25-050234.md) | [598](/filings/0001628280-26-032200.md) | [609](/filings/0001628280-26-053368.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.